115
Separately, scRNA-seq has defined myeloid cell heterogeneity in human blood 22 16, 23 .
118
To generate high-dimensional multi-modal single-cell data from synovial tissue samples,
119
we developed a robust tissue analytical pipeline 24 in the Accelerating Medicines Partnership
120
(AMP) RA/SLE consortium. We collected and disaggregated tissue samples from patients with 121 RA and OA, and then subjected constituent cells to scRNA-seq, sorted-population bulk RNA-122 seq, mass cytometry, and flow cytometry. We developed a robust computational strategy based 
128

RESULTS
129
Generation of parallel mass cytometric and transcriptomic data from synovial tissue
130
In phase 1 of AMP-RA/SLE, we recruited 36 RA patients meeting 1987 ACR classification 131 criteria and 15 OA control patients from 10 clinical sites over 16 months (Supplemental Table   132 1) and obtained synovial tissues from ultrasound guided synovial biopsies or joint replacements Fig. 1b) .
143
Summary of computational data integration strategy to define cell populations
144
To confidently define RA associated cell populations, we used bulk RNA-seq data as the 145 reference point for our study (Fig. 1c) . Bulk RNA-seq data were available for almost all of the 146 samples, had the highest dimensionality and least sparsity, and were the least sensitive to 147 technical artifacts.
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We used CCA to integrate bulk RNA-seq data with the three other datasets (Fig. 1c) .
149
Integrating scRNA-seq with bulk RNA-seq data ensures robust discovery of individual cellular
150
populations. Here, we used CCA to find linear combinations of bulk RNA-seq samples and 151 scRNA-seq cells (Fig. 1d) to create gene expression profiles that were maximally correlated.
152
These linear combinations captured sources of shared variation between the two datasets and 153 allowed us to identify individual cellular populations that drive variation in the bulk RNA-seq 154 data. We clustered scRNA-seq data by using the most correlated canonical variates for each 
157
We identified clusters of cells in mass cytometry data using density-based clustering 25 .
158
To define the genes that best correspond to the mass cytometry clusters, we integrated bulk
159
RNA-seq with mass cytometry using CCA. (Fig. 2a,b) ; in contrast OA tissues had minimal 178 lymphocytic infiltration (Fig. 2a) . This expected heterogeneity reflects variable disease activity 179 among RA patients which results in differences in tissue immune cell infiltration
26
.
180
Consequently, we employed a data-driven approach to separate samples based on the degrees . We defined the maximum OA value (4.5) as a threshold to separate all leukocyte-
185
rich RA samples from leukocyte-poor samples (Methods, Supplemental Fig. 1d ). We defined
186
19 leukocyte-rich RA and 17 leukocyte-poor RA samples in our cohort. Whereas leukocyte-rich
187
RA tissues had marked infiltration of synovial T cells and B cells (Fig. 2c) , leukocyte-poor RA
188
tissues had a similar cellular composition of leukocytes and stromal fibroblasts as OA (Fig. 2c) .
189
Synovial monocytes were similar between RA and OA (Fig. 2c) .
190
Mass cytometry in 26 synovial tissues was consistent with flow cytometric and histologic
191
analyses. We observed marked differences in synovial cellular composition between leukocyte- (Fig. 2f, Supplemental Fig. 3) . In stark contrast, leukocyte-
195
rich RA tissues constituted predominantly of CD4 T, CD8 T, and B cells (Fig. 2f) . Fig. 3a-b, Supplemental Fig. 2b,c) . In contrast,
210
conventional PCA-based clustering led to clusters that were confounded by batch effects 211 (Supplemental Fig. 2d,e) . We selected marker genes for scRNA-seq clusters by comparing donors, suggesting heterogeneity in immune and stromal cell subsets across patients (Fig. 3b) .
218
We show typical markers for cells in a t-Distributed Stochastic Neighbor Embedding (tSNE 29 )
219
into two-dimensional space ( Fig. 3c-f ). Here we briefly summarize these populations. 
244
HLA-DRB1) and the interferon gamma-mediated signaling pathway (IFI30) (Fig. 4a,b 
254
and DNASE1L3, t-test p<1e-3) were significantly decreased in leukocyte-rich RA (Fig. 4c ).
255
Next, we used the most differentially expressed genes (AUC>0.7) in each fibroblast subset to 256 query transcriptomic profiles of bulk-sorted fibroblasts from leukocyte-rich RA and OA synovia.
257
HLA high sublining fibroblasts (SC-F2) and CD34 + sublining fibroblasts (SC-F1) were significantly 258 expanded in RA synovia compared to OA (t-test p=2.5e-6 and p=2.1e-3, respectively), while
259
CD55
+ lining fibroblasts (SC-F4) were relatively decreased in leukocyte-rich RA (t-test p=5.0e-7)
260
( Fig. 4d) .
261
We then queried the proteomic expression to validate these four fibroblast populations. cytokine-producing state (Fig. 4h) . In contrast, the expression of lining fibroblast genes PRG4
268
and CD55 separated in the CCA space with a gradient, indicating relative decreased number of 269 lining fibroblasts in leukocyte-rich synovium (Fig. 4h) . We then integrated each scRNA-seq 270 subset based on the most unique genes (AUC>0.7) with identified the corresponding mass 
285
and IFN-activated monocytes (SC-M4) (Fig. 5a) . GSEA demonstrated that monocyte LPS 286 response was associated with SC-M1 (44.8% of total monocytes) (Fig. 5b) , suggesting it 287 represents a phenotype similar to IL-1-or TLR-activated proinflammatory monocytes. Using
288
Gene Ontology gene sets, we observed that SC-M4 monocytes were highly enriched in the type
289
I interferon signaling and the interferon-gamma mediated pathway (Supplemental Fig. 5a ),
290
including increased expression of IFITM3 22 and IFI6 (Fig. 5a) . 
315
Conversely, monocytes from cluster SC-M2 correlate with CD11c -by mass cytometry and are
316
inversely correlated with inflammatory monocyte populations (z-score=2.7) (Fig. 5i, Table 1 ).
318
Heterogeneity in synovial CD4 and CD8 T cells defined by effector functions
319
Single-cell RNA-seq data defined distinct CD4 + and CD8 + T cell populations (Fig. 6a) .
320
Among CD4 + T cells, expression of CCR7 and SELL were notably higher in SC-T1 and the Zhang, Wei, Slowikowski, Fonseka, Rao et al A single cell map of the RA joint central memory T cells gene set is enriched in SC-T1 expressed genes (Fig. 6a,b) Fig. 6 ).
327
Single-cell RNA-seq analysis of synovial CD8 + T cells identified three unexpected
328
populations characterized by distinct expression of effector molecules GZMK, GZMB, GZMA
329
and GNLY (Fig. 6a) suggestive of an effector phenotype (Fig. 6a,b) . Application of GSEA to these populations 333 annotated each of the six T cell clusters (Fig. 6b) .
334
Many genes specifically expressed by T cell subsets in bulk-sorted T cells were (Fig. 6d) .
341
Using mass cytometry, we identified nine putative T cell clusters among the synovial T 342 cells (CD45 + CD14 -CD3 + ) (Fig. 6e-g, Supplemental Fig. 4c) 
359
(SC-B2), CD11c + ABC cells (SC-B3), and plasmablasts (SC-B4) (Fig. 7a) . Using Gene
360
Ontology pathway enrichment for these four subsets we observed that MHC Class II protein 361 complex and interferon-gamma-mediated signaling pathways (Supplemental Fig. 5b) were 362 enriched in all the HLA + subsets, SC-B1, SC-B2, and SC-B3 (Fig. 3f) (Fig. 7b) . Intriguingly, we observed that SC-B3 cells express high levels of
366
CD11c and T-bet (Fig. 7b) 
372
genes are upregulated in leukocyte-rich RA (n=16) compared to OA (n=7) (Fig. 7c) .
373
Mass cytometric data of synovial B cells (CD45  + CD3   -CD14   -CD19 + ) identified ten 374 putative B cell clusters (Fig. 7d-f, Supplemental Fig. 4d) Fig. 7d-g ).
397
We Fig. 7h-i 
423
We also observed cell subset-specific responses to inflammatory pathways. Toll-like 424 receptor signaling pathway was strongly enriched in B cells and monocytes in leukocyte-rich RA 425 tissues (Fig. 8a) , we elected to use a molecular parameter, based 439 on percent lymphocytes, monocytes of the total cellularity, to classify our samples at the local 440 tissue level. We note that differences in leukocyte enrichment of joint replacement samples and 441 biopsy samples were best explained by leukocyte infiltration and not by the tissue source 442 (Supplemental Fig. 1, Supplemental Fig. 7d-g ).
443
This and previous studies have highlighted stromal fibroblasts as a potential therapeutic lining fibroblasts (SC-F4), which was relatively depleted in human RA. We identified a novel 455 fibroblast subset (SC-F3) characterized by high DKK3 (Fig. 4) , encoding Dickkopf3, and protein 456 upregulated in OA that prevents cartilage degradation in vitro 45, 46 .
457
Transcriptional heterogeneity in the synovial monocyte compartment indicated that 458 distinct RA-enriched subsets are driven by inflammatory cytokines (such as IL-1 or TNF) and 459 interferons (Fig. 5, Fig. 8 ). This suggests monocyte may be sensitive to the local 
465
supported by high levels of MERTK (Fig. 5) 
49
, or an unrecognized monocyte phenotype specific
466
to the normal uninflamed synovium. Alternatively, NUPR1 + markers such as osteoactivin
467
(GPNMB) and cathepsin K (CTSK) could indicate a specific subset of osteoclast progenitors 468 that control bone remodeling (Fig. 5 (Fig. 2b) , which 497 limited our ability to identify RA-associated synovial B cell subsets through case-control 498 comparisons (Fig. 7g) .
499
A Bold mass cytometry clusters are significantly enriched in leukocyte-rich RA (one tailed FDR q value < 0.05). Two significant digits are given to the one tailed MASC p value. 95% confidence interval (CI) for the odds ratio (OR) is given for each mass cytometry cluster.
Where possible, we have identified the most similar scRNA-seq clusters for each cluster found by mass cytometry.
scRNA-seq cluster mass cytometry cluster Table 1 . Connection between cell populations determined by mass cytometry and scRNA-seq clusters and disease associations.
